ST14-BARX2 Fusion FISH Probe
The ST14-BARX2 Fusion FISH Probe is used to confirm a fusion of the ST14 and BARX2 genes. The fusion of the ST14 and BARX2 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| ST14-BARX2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| ST14-BARX2-20-AQAQ | 20 (40 μL) | 200 μL |
|
ST14 Gene Summary
The protein encoded by this gene is an epithelial-derived, integral membrane serine protease. This protease forms a complex with the Kunitz-type serine protease inhibitor, HAI-1, and is found to be activated by sphingosine 1-phosphate. This protease has been shown to cleave and activate hepatocyte growth factor/scattering factor, and urokinase plasminogen activator, which suggest the function of this protease as an epithelial membrane activator for other proteases and latent growth factors. The expression of this protease has been associated with breast, colon, prostate, and ovarian tumors, which implicates its role in cancer invasion, and metastasis. [provided by RefSeq, Jul 2008]
Gene Name: Suppression Of Tumorigenicity 14
Chromosome: CHR11: 130029681 -130080257
Locus: 11q24.3
BARX2 Gene Summary
This gene encodes a member of the homeobox transcription factor family. A highly related protein in mouse has been shown to influence cellular processes that control cell adhesion and remodeling of the actin cytoskeleton in myoblast fusion and chondrogenesis. The encoded protein may also play a role in cancer progression. [provided by RefSeq, Jul 2008]
Gene Name: BARX Homeobox 2
Chromosome: CHR11: 129245880 -129322174
Locus: 11q24.3
Gene Diseases
The ST14 BARX2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|